Genome editing with ARCUS nuclease technology
- HQ
- Durham
- Sector
- biotech
- Stage
- growth
- Total raised
- $300M
- Last round
- growth
Founder profiles, enrichment notes, funding history, and investor connections are available to signed-in members.
Sign in to view full record